Novellia
Novellia, Inc. is a New York-based healthcare data company offering an AI-enabled, patient-controlled personal health record and real-world data platform. Its consumer product consolidates medical records from multiple providers through healthcare-system integrations, organizes and summarizes records to help patients understand their care, and enables patients to explicitly authorize the use of de-identified information for life-sciences research. The company positions its platform as an alternative to fragmented claims, single-provider EHR, and traditional data-broker models by building longitudinal datasets from patient-contributed records. Novellia’s publicly described users and markets include patients, health systems, pharmaceutical companies, and life-sciences teams working in medical affairs, real-world evidence/HEOR, commercial strategy, market access, and R&D.
Company Details
- Website
- novellia.com
- Headquarters
- New York, New York, United States
- Founded
- 2023
- Funding
- $28 million total, including an $18 million Series A announced June 2, 2026
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring